Cargando…
Testing the “RCT augmentation” methodology: A trial simulation study to guide the broadening of trials eligibility criteria and inform on effectiveness
BACKGROUND: Exclusion criteria that are treatment effect modifiers (TEM) decrease RCTs results generalisability and the potentials of effectiveness estimation. In “augmented RCTs”, a small proportion of otherwise-excluded patients are included to allow for effectiveness estimation. In Hodgkin Lympho...
Autores principales: | Nordon, Clementine, Sanchez, Benoit, Zhang, Mei, Wang, Xiaowei, Hunt, Phillip, Belger, Mark, Karcher, Helene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313858/ https://www.ncbi.nlm.nih.gov/pubmed/37397428 http://dx.doi.org/10.1016/j.conctc.2023.101142 |
Ejemplares similares
-
The “RCT augmentation”: a novel simulation method to add patient heterogeneity into phase III trials
por: Karcher, Helene, et al.
Publicado: (2018) -
Analysis of Eligibility Criteria Complexity in Clinical Trials
por: Ross, Jessica, et al.
Publicado: (2010) -
A review of research on eligibility criteria for clinical trials
por: Su, Qianmin, et al.
Publicado: (2023) -
The impact of eligibility criteria on enrollment in ICU sepsis clinical trials
por: Foster, D, et al.
Publicado: (1999) -
Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials
por: van Eijk, Ruben P.A., et al.
Publicado: (2019)